日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

拓宽入组门槛:胰腺癌和胆道癌试验中潜在可修改的研究入组标准分析

Saj, Fen; Namayanja, Felicity K; Xiao, Lianchun; Borad, Mitesh J; Kelley, Robin Kate; Goyal, Lipika; Azad, Nilofer S; Bachini, Melinda; Lindsey, Stacie; Pant, Shubham; Valle, Juan W; Fashoyin-Aje, Lola A; Javle, Milind

Study Designs and Crafting Endpoints for Gene Therapy Development Programs in Rare Disease: A Narrative Review

罕见病基因治疗研发项目的研究设计和终点指标制定:叙述性综述

Murray, Lindsey T; Yin, Yin; Phillips, Dawn; Coats, Julie; Tran, Ha; Dashiell-Aje, Ebony; Rizzo, Marco; Parker, Samantha

Progress in Emergency Medicine in Nigeria: Where we are in 2025

尼日利亚急诊医学进展:2025 年我们将达到什么水平

Olaomi, Oluwole Olayemi; Fasina-Ayoola, Abiola; Tunde-Ayinmode, Mosunmola Florence; Orji, Ernest Okechukwu; Usang, Usang Edet; Desalu, Ibironke; Adesoji, Ademuyiwa; Aje, Akinyemi; Ibeanusi, Sydney; Imogu, Andrew Otunifadhe; Ikem, Innocent; Wahab, Yinusa; Madugu, Nana Hawwa; Ekanem, Emmanuel E; Anumah, Felicia

Ventral striatum temporal interference brain stimulation enhances the reward positivity event-related potential and reduces anxiety

腹侧纹状体颞叶干扰脑刺激可增强奖赏正性事件相关电位并降低焦虑

Ryan, Jonathan S; McDermott, Timothy J; Botzanowski, Boris; Kubert, Jessica R; Betters, Samantha A; Oluwagbohunmi, Aje; Frandsen, Summer B; Fulton, Travis M; Williamson, Adam; Treadway, Michael T; Fani, Negar

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma

FDA批准摘要:Lisocabtagene Maraleucel用于治疗复发或难治性滤泡性淋巴瘤

Britton, Kristen; Mahat, Upendra; Richardson, Nicholas C; Tegenge, Million; Gao, Qianmiao; Theoret, Marc R; Fashoyin-Aje, Lola A

FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

FDA批准摘要:Nadofaragene Firadenovec-vncg用于治疗卡介苗无效的非肌层浸润性膀胱癌

Colbert, Laronna; Jia, Yuxia; Sharma, Anurag; Hu, Jiang; Xu, Zhenzhen; Suzman, Daniel L; Das, Asha; Bross, Peter; Kluetz, Paul G; Fashoyin-Aje, Lola A

FDA Approval Summary: Afamitresgene Autoleucel for Adults with HLA-Restricted, MAGE-A4-Positive Unresectable or Metastatic Synovial Sarcoma after Prior Chemotherapy

FDA批准摘要:Afamitresgene Autoleucel用于治疗既往接受过化疗的HLA限制性、MAGE-A4阳性不可切除或转移性滑膜肉瘤成人患者

Barnett, Katherine K; Johnson, Abigail R; Das, Asha; Lee, Ching-Hsien J; Wang, Cong; Wang, Xiaofei; Cho, Elin S; Kluetz, Paul G; Fashoyin-Aje, Lola A

FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class-Exposed, Relapsed or Refractory Multiple Myeloma

FDA批准摘要:Idecabtagene Vicleucel用于治疗三类药物暴露、复发或难治性多发性骨髓瘤

Sharma, Poornima; Lin, Xue; Xu, Zhenzhen; Kanapuru, Bindu; Theoret, Marc R; Sokolic, Robert; Fashoyin-Aje, Lola A

FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti-PD-1-Based Immunotherapy

FDA批准摘要:Lifileucel用于治疗既往接受过抗PD-1免疫疗法治疗的不可切除或转移性黑色素瘤

Hu, Lianne; Fan, Chaohong; Bross, Peter; Das, Asha; Cho, Elin S; Knudson, Karin M; Tegenge, Million; Gao, Qianmiao; Brewer, Jamie R; Theoret, Marc R; Fashoyin-Aje, Lola A

Clinical epidemiology of atrial fibrillation in heart failure in Abeokuta, Nigeria

尼日利亚阿贝奥库塔心力衰竭患者房颤的临床流行病学研究

Oladeji, Olajide O; Ogah, Okechukwu S; Olunuga, Taiwo O; Durodola, Amina; Adebayo, Saheed O; Aje, Akinyemi; Nwamadiegesi, Caroline A; Ezeh, Chidera H; Adeyeye, Oluwabunmi V; Obiekwe, Franklin E; Eziechina, Collins C; Digwu, Shalom O; Akinosi, Taiwo M; Abhulimen, Enahoro S; Ogah, Chidinma M; Odenigbo, Miracle N; Aniekan, Etim U